Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Quality and security lapses identified during a Food and Drug Administration (FDA) investigation has led to the temporary suspension of production at Johnson & Johnson’s McNeill PPC drug manufacturing plant, located in Fort Washington, Penn., where children’s Tylenol, Motrin, Benadryl and Zyrtec were made. The investigation was followed by a recall of 1,500 lots of the brand name over-the-counter products distributed in the U.S. and internationally. The FDA says it is considering more actions against the company, including possible criminal penalties.

Read the rest of this entry »

A brand of the anesthetic propofol is being recalled by the Food and Drug Administration (FDA) because the injectable emulsion may contain particulate matter that could potentially impede blood flow and lead to serious health issues such as stroke, respiratory failure, kidney failure, liver failure, heart attack and/or stroke. The recall includes 85 lots of Hospira, Inc. brand Liposyn™ II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20%, Liposyn III 30% and 73 lots of Propofol Injectable Emulsion 1% products that begin with the lot numbers 79 and 80. The affected lots were distributed between July 2009 and October 2009.

Read the rest of this entry »